Stocks · Health care · Hospital & Medical Service Plans

Centene Corporation

CNC Clue Score44
United States Fiscal year ends December CIK 0001071739 Results filed 27 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Sarah London
8 Aug 2025
Chief Executive Officer
Buy
19,230
$25.50
$490.37K
Theodore R. Samuels II
28 Jul 2025
Director
Buy indirect
9,000
$27.62
$248.58K
Thomas Greco
18 Dec 2024
Director
Buy
17,000
$59.75
$1.02M
Christopher J Coughlin
16 Dec 2024
Director
Buy
10,000
$59.44
$594.40K
Jessica L. Blume
16 Dec 2024
Director
Buy indirect
250
$59.48
$14.87K
H James Dallas
16 Dec 2024
Director
Buy indirect
1,693
$59.01
$99.90K
Theodore R. Samuels II
13 Dec 2024
Director
Buy indirect
5,000
$58.86
$294.30K
Andrew Lynn Asher
13 Nov 2024
Chief Financial Officer
Buy
17,200
$58.14
$1.00M
Sarah London
8 Nov 2024
Chief Executive Officer
Buy
4,117
$60.80
$250.31K
Sarah London
17 Mar 2023
Chief Executive Officer
Buy
30,000
$62.60
$1.88M
Andrew Lynn Asher
10 Feb 2023
EVP, CFO
Buy
3,800
$71.97
$273.49K
Andrew Lynn Asher
9 Feb 2023
EVP, CFO
Buy
3,000
$71.89
$215.67K
Theodore R. Samuels II
8 Feb 2023
Director
Buy
7,000
$71.88
$503.16K
James E Murray
8 Feb 2023
EVP, Chief Operating Officer
Buy
6,750
$73.30
$494.78K
H James Dallas
29 Apr 2022
Director
Buy
3,065
$81.75
$250.56K
Christopher J Coughlin
29 Apr 2022
Director
Buy
12,000
$81.37
$976.44K
Theodore R. Samuels II
28 Apr 2022
Director
Buy indirect
6,270
$80.94
$507.49K
Robert K Ditmore
26 Feb 2021
Director
Buy indirect
170
$58.45
$9.94K
Jessica L. Blume
26 Jul 2019
Director
Buy
2,850
$52.99
$151.02K

What was left out

Form 4 filings counted 818
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 128
Transactions with no price 0
Shares from compensation/vesting 13,159,756
Sales filed before the plan box existed 118
History held since 2 Oct 2006